IE
CRBU icon

Israel Englander’s Caribou Biosciences CRBU Stock Holding History

Israel Englander’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.1K Sell
51,171
-1,023,250
-95% -$2.02M ﹤0.01% 5521
2026
Q1 		$2.04M Buy
1,074,421
+307,419
+40% +$528K ﹤0.01% 3857
2025
Q4 		$1.22M Sell
767,002
-2,449,533
-76% -$5.14M ﹤0.01% 4345
2025
Q3 		$7.49M Buy
3,216,535
+1,665,946
+107% +$3.14M ﹤0.01% 2696
2025
Q2 		$1.95M Buy
1,550,589
+729,538
+89% +$718K ﹤0.01% 3904
2025
Q1 		$750K Sell
821,051
-38,774
-5% -$50.4K ﹤0.01% 4565
2024
Q4 		$1.37M Buy
859,825
+297,351
+53% +$598K ﹤0.01% 3947
2024
Q3 		$1.1M Sell
562,474
-158,048
-22% -$324K ﹤0.01% 4193
2024
Q2 		$1.18M Buy
720,522
+599,033
+493% +$1.91M ﹤0.01% 3987
2024
Q1 		$624K Buy
121,489
+107,275
+755% +$661K ﹤0.01% 4663
2023
Q4 		$81.4K Sell
14,214
-120,966
-89% -$598K ﹤0.01% 5388
2023
Q3 		$646K Sell
135,180
-587,389
-81% -$3.64M ﹤0.01% 4502
2023
Q2 		$3.07M Buy
722,569
+397,554
+122% +$1.79M ﹤0.01% 3120
2023
Q1 		$1.73M Buy
325,015
+84,972
+35% +$529K ﹤0.01% 3580
2022
Q4 		$1.51M Buy
240,043
+3,928
+2% +$35K ﹤0.01% 3804
2022
Q3 		$2.49M Buy
236,115
+211,199
+848% +$1.97M ﹤0.01% 3544
2022
Q2 		$135K Sell
24,916
-233,350
-90% -$1.78M ﹤0.01% 5809
2022
Q1 		$2.37M Buy
258,266
+766
+0.3% +$8.07K ﹤0.01% 3708
2021
Q4 		$3.89M Buy
257,500
+182,826
+245% +$3.56M ﹤0.01% 3153
2021
Q3 		$1.78M Buy
+74,674
New +$1.83M ﹤0.01% 4057

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Israel Englander's CRBU Position: Q2 2026 in Review

Israel Englander reduced its Caribou Biosciences (CRBU) stake by 95% in Q2 2026, selling an estimated $2.02M and leaving 51,171 shares worth $90.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5521.

Israel Englander first reported a position in CRBU in Q3 2021 and has held it in 20 quarters since. The position peaked at $7.49M in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Israel Englander held 51,171 shares of Caribou Biosciences worth $90.1K as of Q2 2026.
  • Israel Englander sold 1,023,250 Caribou Biosciences shares in Q2 2026, an estimated $2.02M.
  • Caribou Biosciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5521 holding.
  • Israel Englander first reported a position in Caribou Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Israel Englander's Caribou Biosciences position peaked at $7.49M in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.